Mia Visits 2 - 3: A 35-year-old woman with rheumatoid arthritis receiving DMARD therapy

Title:

Mia Visits 2 - 3: A 35-year-old woman with rheumatoid arthritis receiving DMARD therapy

Topic: Rheumatology
Relevant Terms: Arthritis; Early Rheumatoid Arthritis; Joint Erosion; Joint Pain; Rheumatoid Arthritis
Primary Audience: Rheumatologists
Launch Date: 12-Dec-13
Credits: AMA PRA Category 1 Credit
Expiration Date: 11-Dec-14
Curriculum Name: Improving Early Detection and Treatment of Rheumatoid Arthritis

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Decide when patients will likely benefit from the use of biological therapies
  2. List both the benefits and the safety risks of biological therapies in RA
  3. Demonstrate increased competence in their ability to monitor patients with RA who are on biologic therapies

    Faculty

    Michael York, MD
    CME Course Director
    Assistant Professor of Medicine
    Boston University School of Medicine
    Boston, MA
    Naomi Amudala, MSN, RN, FNP-BC
    CNE Course Advisor
    Clinical Instructor and Nurse Practitioner
    Vasculitis Center/Rheumatology
    Boston University School of Medicine
    Boston, MA
    Tuhina Neogi, MD, PhD
    Associate Professor of Medicine and of Epidemiology
    Boston University School of Medicine
    Boston, MA
    DISCLOSURE POLICY STATEMENT
    Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
     
    DISCLAIMER
    THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.
     
    Faculty:
    None of the above faculty have any relevant financial relationships with any commercial interest. None of the faculty plan on discussing unlabeled/investigational uses of a commercial product.

    Accreditation Planning
    Patti-Ann Collins, PhD, MSN, MBA, RN, Lead Nurse Planner, has no relevant financial relationships with any commercial interest.
    Jody Walker, MS, planner, has no relevant financial relationships with any commercial interest.
    Julie White, MS, planner, has no relevant financial relationships with any commercial interest.

    CREDIT DESIGNATIONS
    Boston University School of Medicine designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
     
    CNE Contact Hours: 1.0, all of which are eligible for Pharmacotherapeutic credit.
     
    Nurses will receive contact hours after completion of an evaluation and claim for credit form.
     
    ACCREDITATION STATEMENTS
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine. 

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™, nurses are entitled to receive 1.0 CNE contact hours, all of which are pharmacology credit worthy. Statement of credit will be available to print from your user history page.
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians and nurses who successfully complete the post-test and evaluation will resepectively receive CME or credit. You must score with a 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
       
    Release Date: December 12, 2013 
    Expiration Date: December 11, 2014
    Estimated time to complete: 1.0 hour

    Program Code:
    I.RACHECKPOINTS13
     
    For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
    To view Boston University's Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.
    To view RealCME's Privacy Policy, please see http://www.healthcourse.com/privacy/.

    COMMERCIAL SUPPORT
    This activity is supported by an independent educational grant from AbbVie.
    This activity is supported by an unrestricted educational grant from UCB.
     


    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 18.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
    Safari 4.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above